BAOZUN INC-SPN ADR (BZUN)

US06684L1035 - ADR

2.75  +0.16 (+6.18%)

After market: 2.75 0 (0%)

Fundamental Rating

3

Taking everything into account, BZUN scores 3 out of 10 in our fundamental rating. BZUN was compared to 34 industry peers in the Broadline Retail industry. BZUN may be in some trouble as it scores bad on both profitability and health. BZUN is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

BZUN had negative earnings in the past year.
In multiple years BZUN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: BZUN reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -2.66%, BZUN is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
With a Return On Equity value of -6.79%, BZUN perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BZUN has a Gross Margin of 72.66%. This is amongst the best in the industry. BZUN outperforms 96.97% of its industry peers.
In the last couple of years the Gross Margin of BZUN has grown nicely.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZUN has more shares outstanding
BZUN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BZUN has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.23, BZUN is doing worse than 60.61% of the companies in the same industry.
BZUN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
BZUN has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACCN/A
WACC6.32%

2.3 Liquidity

BZUN has a Current Ratio of 1.94. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
BZUN has a better Current ratio (1.94) than 69.70% of its industry peers.
A Quick Ratio of 1.66 indicates that BZUN should not have too much problems paying its short term obligations.
BZUN has a better Quick ratio (1.66) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.66

4

3. Growth

3.1 Past

The earnings per share for BZUN have decreased strongly by -150.84% in the last year.
Looking at the last year, BZUN shows a small growth in Revenue. The Revenue has grown by 4.90% in the last year.
BZUN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.32% yearly.
EPS 1Y (TTM)-150.84%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-79.53%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y10.32%
Revenue growth Q2Q8.9%

3.2 Future

BZUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 88.69% yearly.
Based on estimates for the next years, BZUN will show a small growth in Revenue. The Revenue will grow by 4.73% on average per year.
EPS Next Y163.25%
EPS Next 2Y127.54%
EPS Next 3Y88.69%
EPS Next 5YN/A
Revenue Next Year2.58%
Revenue Next 2Y4.33%
Revenue Next 3Y4.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZUN. In the last year negative earnings were reported.
BZUN is valuated quite expensively with a Price/Forward Earnings ratio of 28.82.
The rest of the industry has a similar Price/Forward Earnings ratio as BZUN.
BZUN is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 28.82

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BZUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BZUN's earnings are expected to grow with 88.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y127.54%
EPS Next 3Y88.69%

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

BAOZUN INC-SPN ADR

NASDAQ:BZUN (4/26/2024, 7:00:00 PM)

After market: 2.75 0 (0%)

2.75

+0.16 (+6.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap167.65M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.82
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 72.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.94
Quick Ratio 1.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-150.84%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y163.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y